This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
investing: Archive
Bear of the Day: Qualcomm (QCOM)
by Shaun Pruitt
Until there is a resolution to the memory chip shortage, it wouldn't be surprising if there is more volatility ahead for Qualcomm stock.
QCOMNegative Net Change WDCNegative Net Change SNDKNegative Net Change
artificial-intelligence earnings electronics investing large-cap semiconductor tech-stocks
Bull of the Day: Gold.com (GOLD)
by Shaun Pruitt
Amid an unprecedented commodity price boom for various precious metals, Gold.com's stock has been one of the market's top performers in 2026.
GOLDNegative Net Change
earnings finance gold investing precious-metals
Trend, Risk, & Resilience: A Guide to Profitable Trading (I Wish I Knew This Earlier)
by Andrew Rocco
While 99% of day traders fail, you can tilt the odds in your favor by shifting your focus from predicting the market to mastering risk management and trend-following mechanics.
WDCNegative Net Change STXNegative Net Change MUPositive Net Change NVDAPositive Net Change SNDKNegative Net Change OKLOPositive Net Change
investing
Vertiv Holdings: Powering the AI Boom with Critical Infrastructure Solutions
by Bryan Hayes
This stock has risen nearly 25% this year alone amid broadening recognition of its role in the AI ecosystem.
VRTPositive Net Change
artificial-intelligence cloud-computing computers datacenter earnings electronics infrastructure investing semiconductor tech-stocks
2 Intriguing Medical Stocks to Watch as Q4 Results Approach: EXEL, GILD
by Shaun Pruitt
With their Q4 results approaching after-market hours on Tuesday, February 10, Exelixis (EXEL) and Gilead Sciences (GILD) are two top-performing medical stocks to consider.
GILDPositive Net Change EXELNegative Net Change BAYRYNegative Net Change
biotechnology biotechs earnings investing medical
Buy the Dip in Amazon Stock After Mixed Q4 Results & CapEx Concerns?
by Shaun Pruitt
In the aftermath of its Q4 post-earnings selloff, Amazon stock is trading near its cheapest P/E valuation in a decade.
AMZNNegative Net Change MSFTPositive Net Change GOOGLNegative Net Change METAPositive Net Change
ad-tech advertising artificial-intelligence cloud-computing e-commerce earnings investing large-cap magnificent-7 retail tech-stocks
The Rotation into Consumer Staples: Defensive Strength in an Uncertain 2026
by Bryan Hayes
Staples have become one of the sole areas of relative strength this year amid broader selloffs, attracting record inflows as portfolios de-risk.
KONegative Net Change PMNegative Net Change XLPNegative Net Change
consumer-staples dividend-investing dividends earnings emerging-markets inflation interest-rate investing tech-stocks
Is Gilead Sciences (GILD) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
by Bryan Hayes
The company's market-leading HIV franchise has fueled top-line growth.
GILDPositive Net Change
biotechnology cancer cell-therapy earnings investing medical oncology-screening stock-performance
Buy Alphabet Stock After Strong Q4 Results or is it Too Soon?
by Shaun Pruitt
Posting strong Q4 results yesterday evening, Alphabet (GOOGL) stock still dipped half a percentage point in Thursday's trading session as investors pondered its massive spending plans.
GOOGLNegative Net Change AMZNNegative Net Change MSFTPositive Net Change METAPositive Net Change
ad-tech advertising artificial-intelligence cloud-computing earnings investing tech-stocks
Bear of the Day: Albany International (AIN)
by Bryan Hayes
Sales growth has been anemic in recent years and well below other industrial companies.
AINPositive Net Change
aerospace apparel earnings industrial-products investing